BC
RDY icon

Bayforest Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Bayforest Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
+837
New +$11.3K 0.01% 826
2025
Q3 		– Sell
-5,083
Closed -$76.4K – 891
2025
Q2 		$76.4K Buy
+5,083
New +$72.6K 0.03% 502

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bayforest Capital's RDY Position: Q2 2026 in Review

Bayforest Capital opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 837 shares worth $12.1K. The stake represents 0.01% of the portfolio and ranks #826 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in RDY as recently as Q2 2025.

Bayforest Capital first reported a position in RDY in Q2 2025 and has held it in 2 quarters since. The position peaked at $76.4K in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Bayforest Capital held 837 shares of Dr. Reddy's Laboratories worth $12.1K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Bayforest Capital position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.01% of Bayforest Capital's portfolio in Q2 2026, its #826 holding.
  • Bayforest Capital first reported a position in Dr. Reddy's Laboratories in Q2 2025 and has held it in 2 quarters since.
  • Bayforest Capital's Dr. Reddy's Laboratories position peaked at $76.4K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.